Russia Attracts More Multinational Pharmas As Emerging Markets Continue To Bloom
This article was originally published in PharmAsia News
Executive Summary
Indian drug maker Ranbaxy is moving swiftly to capitalize on Russian policies to encourage establishing a local production presence, signing a memorandum of understanding with Russia's Yaroslavl regional authority to help the province build a medical and pharmaceutical center. The "going local, going to regions" move could set a model for international pharma companies eying the Russian market, says a Russia biologics expert